• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向金属酶治疗干预。

Targeting Metalloenzymes for Therapeutic Intervention.

机构信息

Department of Chemistry and Biochemistry , University of California, San Diego , La Jolla , California 92093 , United States.

出版信息

Chem Rev. 2019 Jan 23;119(2):1323-1455. doi: 10.1021/acs.chemrev.8b00201. Epub 2018 Sep 7.

DOI:10.1021/acs.chemrev.8b00201
PMID:30192523
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6405328/
Abstract

Metalloenzymes are central to a wide range of essential biological activities, including nucleic acid modification, protein degradation, and many others. The role of metalloenzymes in these processes also makes them central for the progression of many diseases and, as such, makes metalloenzymes attractive targets for therapeutic intervention. Increasing awareness of the role metalloenzymes play in disease and their importance as a class of targets has amplified interest in the development of new strategies to develop inhibitors and ultimately useful drugs. In this Review, we provide a broad overview of several drug discovery efforts focused on metalloenzymes and attempt to map out the current landscape of high-value metalloenzyme targets.

摘要

金属酶在广泛的重要生物活性中起着核心作用,包括核酸修饰、蛋白质降解和许多其他功能。金属酶在这些过程中的作用也使它们成为许多疾病进展的核心,因此,金属酶成为治疗干预的有吸引力的靶点。人们对金属酶在疾病中的作用及其作为一类靶点的重要性的认识不断提高,这也促使人们加大了开发新策略以开发抑制剂并最终开发出有用药物的兴趣。在这篇综述中,我们提供了对几种专注于金属酶的药物发现努力的广泛概述,并试图描绘出高价值金属酶靶点的当前格局。

相似文献

1
Targeting Metalloenzymes for Therapeutic Intervention.靶向金属酶治疗干预。
Chem Rev. 2019 Jan 23;119(2):1323-1455. doi: 10.1021/acs.chemrev.8b00201. Epub 2018 Sep 7.
2
Zinc metalloenzymes as new targets against the bacterial pathogen Brucella.锌金属酶作为抗细菌病原体布鲁氏菌的新靶标。
J Inorg Biochem. 2012 Jun;111:138-45. doi: 10.1016/j.jinorgbio.2011.10.019. Epub 2011 Dec 1.
3
A Bioinorganic Approach to Fragment-Based Drug Discovery Targeting Metalloenzymes.基于生物无机的方法进行针对金属酶的基于片段的药物发现。
Acc Chem Res. 2017 Aug 15;50(8):2007-2016. doi: 10.1021/acs.accounts.7b00242. Epub 2017 Jul 17.
4
Emerging trends in metalloprotein inhibition.金属蛋白酶抑制的新趋势。
Dalton Trans. 2011 Apr 14;40(14):3445-54. doi: 10.1039/c0dt01743d. Epub 2011 Feb 2.
5
Targeting metalloenzymes: a strategy that works.靶向金属酶:一种行之有效的策略。
Curr Opin Pharmacol. 2003 Oct;3(5):502-7. doi: 10.1016/s1471-4892(03)00115-2.
6
Targeting Metalloenzymes by Boron-Containing Metal-Binding Pharmacophores.靶向含硼金属结合药效团的金属酶
J Med Chem. 2021 Dec 23;64(24):17706-17727. doi: 10.1021/acs.jmedchem.1c01691. Epub 2021 Dec 7.
7
Investigating the selectivity of metalloenzyme inhibitors.研究金属酶抑制剂的选择性。
J Med Chem. 2013 Oct 24;56(20):7997-8007. doi: 10.1021/jm401053m. Epub 2013 Oct 14.
8
Aberrance of Zinc Metalloenzymes-Induced Human Diseases and Its Potential Mechanisms.锌金属酶的失常导致的人类疾病及其潜在机制。
Nutrients. 2021 Dec 13;13(12):4456. doi: 10.3390/nu13124456.
9
Isosteres of hydroxypyridinethione as drug-like pharmacophores for metalloenzyme inhibition.羟吡啶硫酮类似物作为金属酶抑制作用的类药药效团。
J Biol Inorg Chem. 2018 Oct;23(7):1129-1138. doi: 10.1007/s00775-018-1593-1. Epub 2018 Jul 12.
10
Metalloenzymes as Therapeutic Targets.金属酶作为治疗靶点
Curr Med Chem. 2019;26(15):2556-2557. doi: 10.2174/092986732615190725122012.

引用本文的文献

1
Manganese-dependent iron-superoxide dismutase drives Acinetobacter baumannii fitness during oxidative stress.锰依赖的铁超氧化物歧化酶在氧化应激期间驱动鲍曼不动杆菌的适应性。
J Biol Chem. 2025 Aug 5;301(9):110549. doi: 10.1016/j.jbc.2025.110549.
2
Beyond natural flavonoids: exploring bioisosterism in design and synthesis of influenza endonuclease inhibitors.超越天然黄酮类化合物:探索流感病毒内切酶抑制剂设计与合成中的生物电子等排原理。
RSC Med Chem. 2025 Mar 11. doi: 10.1039/d5md00071h.
3
Polymorphism rs259983 of the gene is associated with the risk of anemia in pregnant women with gestational diabetes.

本文引用的文献

1
New tricks for human farnesyltransferase inhibitor: cancer and beyond.人类法尼基转移酶抑制剂的新应用:癌症及其他领域
Medchemcomm. 2017 Feb 16;8(5):841-854. doi: 10.1039/c7md00030h. eCollection 2017 May 1.
2
X-ray Crystal Structure of a Bisubstrate Inhibitor Bound to the Enzyme Catechol-O-methyltransferase: A Dramatic Effect of Inhibitor Preorganization on Binding Affinity.与儿茶酚-O-甲基转移酶结合的双底物抑制剂的X射线晶体结构:抑制剂预组织对结合亲和力的显著影响。
Angew Chem Int Ed Engl. 2001 Nov 5;40(21):4040-4042. doi: 10.1002/1521-3773(20011105)40:21<4040::AID-ANIE4040>3.0.CO;2-C.
3
Baloxavir: First Global Approval.
该基因的多态性rs259983与妊娠期糖尿病孕妇的贫血风险相关。
Egypt J Med Hum Genet. 2025;26(1):94. doi: 10.1186/s43042-025-00723-6. Epub 2025 Jun 3.
4
Alleviation of Neurological Disorders by Targeting Neurodegenerative-Associated Enzymes: Natural and Synthetic Molecules.通过靶向神经退行性相关酶缓解神经疾病:天然和合成分子
Int J Mol Sci. 2025 May 14;26(10):4707. doi: 10.3390/ijms26104707.
5
A Ketol-Acid Reductoisomerase Inhibitor That Has Antituberculosis and Herbicidal Activity.一种具有抗结核和除草活性的酮醇酸还原异构酶抑制剂。
Chemistry. 2025 Jun 26;31(36):e202501158. doi: 10.1002/chem.202501158. Epub 2025 Jun 9.
6
Insights into Active Site Cysteine Residues in Enzymes: Potential Targets for Anti-Tuberculosis Intervention.酶活性位点半胱氨酸残基的见解:抗结核干预的潜在靶点
Int J Mol Sci. 2025 Apr 18;26(8):3845. doi: 10.3390/ijms26083845.
7
X-ray Absorption Spectroscopy of Dilute Metalloenzymes at X-ray Free-Electron Lasers in a Shot-by-Shot Mode.在逐次测量模式下利用X射线自由电子激光对稀溶液金属酶进行X射线吸收光谱分析
J Phys Chem Lett. 2025 Apr 17;16(15):3778-3787. doi: 10.1021/acs.jpclett.5c00399. Epub 2025 Apr 7.
8
ERAP1 Activity Modulates the Immunopeptidome but Also Affects the Proteome, Metabolism, and Stress Responses in Cancer Cells.内质网氨肽酶1(ERAP1)的活性调节免疫肽组,但也影响癌细胞中的蛋白质组、代谢和应激反应。
Mol Cell Proteomics. 2025 May;24(5):100964. doi: 10.1016/j.mcpro.2025.100964. Epub 2025 Apr 4.
9
Second coordination sphere regulates nanozyme inhibition to assist early drug discovery.第二配位层调节纳米酶抑制作用以助力早期药物发现。
Nat Commun. 2025 Apr 1;16(1):3123. doi: 10.1038/s41467-025-58291-7.
10
Feature Reviews in Medicinal Chemistry.药物化学专题评论
Pharmaceuticals (Basel). 2025 Feb 14;18(2):260. doi: 10.3390/ph18020260.
巴洛沙韦:全球首次获批
Drugs. 2018 Apr;78(6):693-697. doi: 10.1007/s40265-018-0899-1.
4
Kinase inhibitors: the road ahead.激酶抑制剂:前路漫漫。
Nat Rev Drug Discov. 2018 May;17(5):353-377. doi: 10.1038/nrd.2018.21. Epub 2018 Mar 16.
5
Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form.靶向免疫调节酶吲哚胺 2,3-双加氧酶的去辅基形式可有效抑制其活性。
Proc Natl Acad Sci U S A. 2018 Mar 27;115(13):3249-3254. doi: 10.1073/pnas.1719190115. Epub 2018 Mar 12.
6
Structural and Kinetic Studies of the Potent Inhibition of Metallo-β-lactamases by 6-Phosphonomethylpyridine-2-carboxylates.6-膦酰甲基吡啶-2-羧酸盐对金属β-内酰胺酶的强效抑制作用的结构与动力学研究
Biochemistry. 2018 Mar 27;57(12):1880-1892. doi: 10.1021/acs.biochem.7b01299. Epub 2018 Mar 9.
7
HTS by NMR for the Identification of Potent and Selective Inhibitors of Metalloenzymes.利用核磁共振波谱进行高通量筛选以鉴定金属酶的强效和选择性抑制剂
ACS Med Chem Lett. 2018 Jan 17;9(2):137-142. doi: 10.1021/acsmedchemlett.7b00483. eCollection 2018 Feb 8.
8
Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials.临床试验中HIF脯氨酰羟化酶抑制剂的分子和细胞机制
Chem Sci. 2017 Nov 1;8(11):7651-7668. doi: 10.1039/c7sc02103h. Epub 2017 Sep 11.
9
((S)-3-Mercapto-2-methylpropanamido)acetic acid derivatives as metallo-β-lactamase inhibitors: Synthesis, kinetic and crystallographic studies.((S)-3-巯基-2-甲基丙酰胺基)乙酸衍生物作为金属β-内酰胺酶抑制剂的研究:合成、动力学和晶体学研究。
Eur J Med Chem. 2018 Feb 10;145:649-660. doi: 10.1016/j.ejmech.2018.01.032. Epub 2018 Jan 11.
10
2017 FDA drug approvals.2017年美国食品药品监督管理局批准的药物
Nat Rev Drug Discov. 2018 Feb;17(2):81-85. doi: 10.1038/nrd.2018.4. Epub 2018 Jan 19.